(Q40102556)

English

Reversal of methylation silencing of Apo2L/TRAIL receptor 1 (DR4) expression overcomes resistance of SK-MEL-3 and SK-MEL-28 melanoma cells to interferons (IFNs) or Apo2L/TRAIL.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Reversal of methylation silencing of Apo2L/TRAIL receptor 1 (DR4) expression overcomes resistance of SK-MEL-3 and SK-MEL-28 melanoma cells to interferons (IFNs) or Apo2L/TRAIL. (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

author name string

S I Bae

1

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

V Cheriyath

2

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

B S Jacobs

3

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

F J Reu

4

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

E C Borden

5

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

language of work or name

0 references

publication date

23 July 2007

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

27

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

490-498

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

https://scigraph.springernature.com/pub.10.1038/sj.onc.1210655

0 references

Death receptors: signaling and modulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210655

21 January 2018

Downregulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L/TRAIL-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210655

21 January 2018

Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210655

21 January 2018

Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210655

21 January 2018

X-linked IAP is a direct inhibitor of cell-death proteases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210655

21 January 2018

Epigenetics in human disease and prospects for epigenetic therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210655

21 January 2018

Gene silencing in cancer in association with promoter hypermethylation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210655

21 January 2018

Profiling epigenetic inactivation of tumor suppressor genes in tumors and plasma from cutaneous melanoma patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210655

21 January 2018

Silencing of death receptor and caspase-8 expression in small cell lung carcinoma cell lines and tumors by DNA methylation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210655

21 January 2018

Epigenetic silencing of multiple interferon pathway genes after cellular immortalization.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210655

21 January 2018

Novel growth and death related interferon-stimulated genes (ISGs) in melanoma: greater potency of IFN-beta compared with IFN-alpha2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210655

21 January 2018

Identification of X-linked inhibitor of apoptosis-associated factor-1 as an interferon-stimulated gene that augments TRAIL Apo2L-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210655

21 January 2018

Identification of XAF1 as an antagonist of XIAP anti-Caspase activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210655

21 January 2018

Regulation of the promoter activity of interferon regulatory factor-7 gene. Activation by interferon snd silencing by hypermethylation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210655

21 January 2018

XAF1 expression is significantly reduced in human melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210655

21 January 2018

Overcoming resistance to interferon-induced apoptosis of renal carcinoma and melanoma cells by DNA demethylation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210655

21 January 2018

Expression of RASSF1A, an epigenetically silenced tumor suppressor, overcomes resistance to apoptosis induction by interferons

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210655

21 January 2018

How cells respond to interferons

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210655

21 January 2018

Identifiers

10.1038/SJ.ONC.1210655

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40102556&oldid=1483359766"